Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART.

Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART. Abstract Text:

Benigno Rodriguez,Hernan Valdez,Anne Mijch,Kerrie Watson,Michael M Lederman,Grace A McComsey,Chariclia V Loupa,Ian Woolley,

Background: Statins are increasingly used in HIV-infected patients, but the effect of their immunomodulatory properties on antiretroviral-induced immune reconstitution is unknown. METHODS: The authors compared 6-month and 1-year changes in CD4 T-cell count, plasma HIV ribonucleic acid (RNA), and serum lipids in 69 HIV-infected patients receiving statins and 127 controls matched by age, nadir CD4 T-cell count, and hepatitis C serostatus. All patients were receiving highly active antiretroviral therapy (HAART). The authors used standard statistical tests for univariate comparisons and estimated average change in outcome measurements through repeated measures general linear models. RESULTS: Patients receiving statins had significantly higher median CD4 T-cell counts (430 vs 225 cells/microL, P < .001) and lower HIV RNA levels (2.3 vs 2.9 log10 copies/mL, P < .001) than controls. Statin-treated patients had diminished CD4 T-cell gain at 6 months, but this difference was not statistically significant at 12 months, despite similar 12-month virologic success rates. Patients receiving statins gained, on average, an estimated 60 fewer CD4 T-cells in the first 6 months than controls. Conclusions: Exposure to statins was associated with decreased CD4 T-cell gains during HAART in a cohort of HIV-infected patients, despite adequate virologic response. Studies with longer follow-up and detailed metabolic and immunologic monitoring are needed to confirm these findings and assess their significance and mechanisms.

Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART. Publishing Authors By Initials

B Rodriguez,H Valdez,A Mijch,K Watson,MM Lederman,GA McComsey,CV Loupa,I Woolley,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of the International Association of Physic

VOLUME: 6

Page Numbers: 198-202

Journal Abbreviation:

ISSN: 1545-1097

DAY: 19

MONTH: 06

YEAR: 2007

Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101185740

Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART.

AFFILIATION: University Hospitals of Cleveland and Case Western Reserve University Center for AIDS Research, Cleveland, OH, rodriguez.benigno@clevelandactu.org.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Int Assoc Physicians AIDS Ca

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART Related Publications

• Asymmetric interlimb transfer of concurrent adaptation to opposing dynamic forces.
• Biologic activity of adriamycin (NSC-123127) in microbial systems.
• Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels.
• DNA-templated nanotube localization.
• DNA-templated three-branched nanostructures for nanoelectronic devices.
• Electrically actuated, pressure-driven liquid chromatography separations in microfabricated devices.
• Electrostatic interactions at charged lipid membranes. Hydrogen bonds in lipid membrane surfaces.
• Estrogen mobilizes a subset of estrogen receptor-alpha-immunoreactive vesicles in inhibitory presynaptic boutons in hippocampal CA1.
• Femoral venous thrombosis in a 5-week old with diabetic ketoacidosis and a femoral venous catheter.
• In-channel atom-transfer radical polymerization of thermoset polyester microfluidic devices for bioanalytical applications.
• Isolation of some crystalline yellow peptides from enzymic digests of dinitrophenyl insulin and dinitrophenyl trypsinogen.
• Location of the pirouette gene in Mus musculus.
• Mitomycin C: experience in the United States, with emphasis on gastric cancer.
• Morphological sex differences and laterality in the prepubertal medial amygdala.
• Pharmacological properties of some antimetabolites of serotonin having unusually high activity on isolated tissues.
• Phase-changing sacrificial layer fabrication of multilayer polymer microfluidic devices.
• Phase-changing sacrificial materials for interfacing microfluidics with ion-permeable membranes to create on-chip preconcentrators and electric field gradient focusing microchips.
• Purification of an influenza virus substrate, and demonstration of its competitive antagonism to apple pectin.
• Rapid prototyping of poly(methyl methacrylate) microfluidic systems using solvent imprinting and bonding.
• Sacrificial layer microfluidic device fabrication methods.
• Spontaneous basophilic tumors of the pituitary glands in gonadectomized mice.
• Stabilization of folded peptide and protein structures via distance matching with a long, rigid cross-linker.
• Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART.
• Studies on the structure of lycomarasmin.
• Synthesis and determination of lycomarasmin activity of some derivatives of aspartic acid.
• The adrenal cortex and its tumors.
• The binding of a neutral aromatic molecule to a negatively-charged lipid membrane I. Thermodynamics and mode of binding.
• The emotional aspects of physical disease.
• Therapy in the private practice of psychiatry.
• Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Use of tamsulosin in patients with urinary calculi to increase spontaneous stone passage.